Companies/CA/MSCL

SATELLOS BIOSCIENCE INC.

Last · TorontoC$9.50-0.40 (-4.04%)close · yahoo · 16h ago
Vol 6.1K ≈ 57.8K
Market capC$201.6M21.2M sh
P/E · TTM-3.8fwd -5.0 · eps -2.70 · loss
Beta1.15vs S&P 500
Div yield0.00%annual · TTM
52w range
C$7.56C$18.98
Volume6.1Ksession

Issuer

Legal nameSATELLOS BIOSCIENCE INC.
HQCanada (CA)
ListingCA MSCL
ISINCA80401L8033
LEI529900EN243BZ5QC9N39
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyCAD
Entity registrytsx:MSCL
Org IDMSCL
Websitesatellos.com
Employees20
AddressSatellos Bioscience, Inc. Royal Bank Plaza, South Tower M5J 2J1, Toronto
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.60
Est. revenue
0
View upcoming earnings →

Press & signals

2 recent
  • GlobeNewswire

    Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FSHD Canada Foundation Providing Non-Dilutive Financing to Support Clinical Development

  • GlobeNewswire

    Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress

Documents

FormReporting forFiledFlags
quarterly reportFinancial Results and Operational HighlightsIR
—2026-06-30≈0
otherManagement’s Discussion AnalysisIR
—2026-06-30≈0
quarterly reportFinancial Results and Operational HighlightsIR
—2026-03-31≈0
financial tablesManagement’s Discussion AnalysisIR
—2026-03-31≈0
annual reportFinancial Results and Operational HighlightsIR
—2025-12-31≈0
Showing 5 of 62 filings